Opening for seven Executive posts at Virchow Biotech Pvt Ltd, Hyderabad

Courtesy Bioclues

Virchow Biotech Private Limited (VBPL), an innovative biotechnology company headquartered at Hyderabad, India. VBPL also has offices located in the United States of America ( at Nashville, Tennessee) With an aim of establishing itself in the sunrise industry of biotechnology, Virchow Biotech (P) Ltd commenced its Indian operations in the year 2001. The focus was to develop and manufacture a wide range of unique biologicals and high value bio-generic products at an affordable price. Since then we made impressive strides in terms of product development and have built a strong foundation with a commitment to innovation and process efficiencies. We have rapidly cornered a name for ourselves as a developer of cutting edge therapies in this rapidly evolving biotechnology space.

Post : Executives

• No of Opening : Seven
• Experience : 1 to 3 yrs
• Job Desciption : Candidate must have good knowledge in handling HPLC analytical instrument and water analysis system in Quality Control department.
• Salary : INR 1,00,000 - 3,00,000 P.A
• Education : M.Sc - Biology, Bio-Chemistry, Microbiology
• Location : Hyderabad

Contact Details :Executive Name : Mr.Anil
Contact Company : Virchow Biotech Pvt Ltd
Email Address : hr.virchowbiotech@gmail.com

Deadline : 09.04.12

15 opening for Executive Production post at Dr Reddy's Lab

Dr. Reddy's, recognized consistently amongst the top pharma companies in Asia.

Post : Executive Production
No of Post : 15
Experience : 2 to 6 yrs
Job Description :1.Should be able to understand equipment / capacities and schedule manufacturing.
2.Coordinating with delivery planners for mart requirement and materials availability.
3.Ensure smooth functioning and timely delivery as per commitment given
4.Close monitoring of flow to reduce lead times, inventories and improve up times of
equipments
Education : PG - Biology, Life Science
Location : Hyderabad

Contact Details :Executive Name:Murthy
Contact Company:Dr Reddys Laboratories Ltd
Address: 8-2-337, Road No 3,
Banjara Hills HYDERABAD,Andhra Pradesh,India 500034
Email Address : murthyvvnrc@drreddys.comReference Id:Production Planning

Deadline : 29.03.12

Positions for Freshers

Opportunity for Freshers as Medical Editor post at Cactus Communications, Mumbai Cactus Communications is a pioneering language services company serving more than 25,000 clients across 73 countries. In line with its mission—growth through effective communication, Cactus offers specialist academic editing, medical communications, publication support, transcription, and training services to individuals and corporations across sectors such as academia, publishing, and pharmaceuticals.  Candidates with scientific field degree apply for Specialist – CSD Job at Novartis A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes us one of the most rewarding employers in our field. Designation : Specialist – CSD Job Description Freshers jobs at Jubilant LifeSciences – Biotech/ Biochem/ Microbiology Jubilant Biosys Ltd, is a part of the Jubilant LifeSciences family of companies with R&D centers in India and the USA and business offices in Asia and North America. Jubilant Biosys has global reach and provides comprehensive drug discovery services – from target discovery to clinical development in partnership with leading healthcare companies worldwide. Freshers apply for Area sales Manager – Life Science Division at GE Healthcare, India GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. GE Healthcare’s expertise in medical imaging and information technologies, medical diagnostics, patient monitoring and life support systems, disease research, drug discovery, and biopharmaceutical manufacturing technologies is helping physicians detect disease earlier and to tailor personalized treatments for patients. GE Healthcare

Biotechnopreneur Camps 2012

Gujarat State Biotechnology Mission (GSBTM), Gujarat Venture Finance Limited (GVFL) & Foundation for MSME Clusters (FMC)

along with SkyQuest Technology Consulting Pvt. Ltd. (Knowledge Partner)

PRESENTS

BIOTECHNOPRENEUR^TM CAMPS 2012

Life Sciences | Medical Devices | Biotechnology | Pharmaceuticals

Fostering Technology based Entrepreneurship in Gujarat

The journey of Biopreneur Camps 2011 from Surat, Vallabh Vidyanagar, Baroda and Ahmedabad saw 100 participants at each venue; graced by the presence of eminent guests including Mr. Ketan Patel, MD, Troikaa Pharmaceuticals, Dr. Chandan Chatterjee, Director, The Centre for Entrepreneurship Development (CED), Govt. of Gujarat; Dr. Ravi Dhar, Senior Consultant – Biotechnology Industry Research Assistance Programme (BIRAP) of Dept. of Biotechnology, Govt. of India, Dr. V. S. Patel, Ex-Vice Chancellor, S. P. University and Director, Sophisticated Instrumentation Centre for Applied Research and Testing (SICART) and many more in addition to Shri Mihir Joshi, MD, GVFL; Dr. A. S. Rao, Ex-Sr. Advisor, Dept. of Science & Technology, Govt. of India and currently, also Advisor, FMC and Shri A. K. Saxena IFS, Mission Director, GSBTM, Department of Science & Technology, Govt. of Gujarat.

The programme helped many researchers to turn their science project into business idea and many entrepreneurs to get new ideas.

Biotechnopreneur^TM Camps 2012 is a platform for budding entrepreneurs, researchers and students to understand various aspects of biotech entrepreneurship from industry leaders, successful entrepreneurs, representatives of Government and academicians.

Key features of Biotechnopreneur^TM Camps 2012:

~         Pitch your Business Idea: Seek assistance at any stage for your technology idea

~         My Story Session: Get inspiration from Successful Biotechnology Entrepreneurs

~         Plenary Sessions

~         Network: Interact and with experts and consultants from diverse fields (Technology, Market, Finance, Policies etc.)

Biotechnopreneur^TM team invites you to “PITCH YOUR BUSINESS IDEA” - An opportunity to present your business idea among a panel of technology experts, businessmen and investors. 

Pitch your Business Idea and you will get a chance to seek mentoring & support to start your own biotechnology based business venture.

Eligibility:

Business Idea/Concept/Venture in Lifesciences domain

Applicants from the State of Gujarat

Who can apply?

• Budding Entrepreneurs/Start-ups
• Innovators planning a venture based on their innovation/s
• Researchers looking to take their technology to market 

Shortlisted Applicants will get a 15 minute slot to present your business idea at Biotechnopreneur^TM Camps 2012 and will be offered support like mentoring, strategic advisory, getting investor-ready, applying for funding.

Venues:

Ahmedabad | Mehsana| Rajkot | Surat | Vadodara

Documents to be submitted (Only Soft Copy):

1. Business Idea – Concept note
2. Anticipated Support  (not more than 200 words)
3. Detailed profile of Applicant
4. Scanned Passport size Photograph 

Deadline for Application:

The entries should reach us by email (neha.jhala@skyquestt.com) latest by 31^st December 2011 by 5:00pm

Note:- Subject should be “Pitch Your Business Idea – Biotechnopreneur Camps 2012”

For any further clarification or details, write to Ms. Neha Jhala on neha.jhala@skyquestt.com

PerkinElmer Announces Financial Results for the Third Quarter of 2011

PerkinElmer reported after the close of the market on Thursday that revenues in the third quarter rose 8 percent year over year, but it missed analyst estimates on the top line.

Total revenues in the quarter ended Oct. 2 rose to $453.7 million, compared to $419.1 million a year ago but fell short of Wall Street estimates of $469.6 million. On an organic basis, revenues were up 4 percent year over year.

The firm has made a number of purchases throughout 2011 and in the quarter those acquisitions contributed more than $20 million to the top line, CFO Frank Wilson said on a conference call after the release of the company's earnings results.

The Human Health segment grew revenues to $207.4 million, up 7 percent from $194.5 million a year ago, while Environmental Health climbed to $246.3 million, a 10 percent increase from $224.6 million a year ago.

On the conference call, Chairman and CEO Robert Friel said that during the quarter, growth was seen across all major geographies and most end markets.

The Waltham, Mass.-based company grew sales in Europe in the low-single digits. While 30 percent of the company's business is tied to Europe, Friel said that much of that is in end markets that will not be significantly impacted by the challenging macroeconomic environment there. Only about 5 percent of total revenues is tied directly to government spending that could be exposed to austerity measures in Europe, he said.

The US grew in the mid-single digits, and while macro conditions will be challenging, he said that the company is seeing improving birth rates, which could benefit its newborn screening business, and continued demand for environmental and safety products.

The US academic/government end market represents about 10 percent of revenues, with a large portion of PerkinElmer's exposure in that market in the newborn screening space, which is primarily state funded. Friel said that as long as he's been with the company, he has never seen a decline in funding for newborn screening from states, and in the third quarter, PerkinElmer's newborn screening business grew.

In developing geographies, business rose in the double-digits, and PerkinElmer expects that to continue, Friel said

Do you wish to know more

PerkinElmer to Acquire Caliper Life Sciences for Approximately $600 Million

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for $10.50 per share, for a total net purchase price of approximately $600 million in cash.

Robert F. Friel, chairman and chief executive officer, PerkinElmer, said, "The acquisition of Caliper Life Sciences brings innovative molecular imaging and detection technologies to our portfolio, complementing our world-leading offerings in life science, diagnostics, environmental and food markets."

Friel added, "The R&D, application expertise, and intellectual property of the combined organization will provide our customers with enhanced knowledge and services and a strong pipeline of innovation. Additionally, the proven leadership and talent of the Caliper team will be a strong addition to our organization."

The combined technology platforms will expand PerkinElmer's deep portfolio of solutions and services for global customers.

Do you wish to know more? 

Persistent Buys Agilent's Software Marketing and Development Business

Persistent Systems Ltd (PSL) has signed an agreement to acquire Agilent Technologies' software marketing and development business unit based in Grenoble, France.

The acquisition is expected to be final by August 1, after which the unit will be called Persistent Systems, France.

Dr Anand Deshpande, Chairman and Managing Director, PSL said the acquisition will contribute to Persistent's thrust in the life sciences and healthcare markets and also give it a presence in Europe.

Around 30 domain experts from Agilent will come on board once the transaction is completed and more may be added, he said.

The Agilent business is now focused on supplying data acquisition and control software for scientific instruments to the life sciences, environmental, energy, applied research and other markets. Currently, PSL's Life Sciences business contributes 10-12 per cent to its topline and was worth $20 million in FY 2011.

The team here includes over 40 domain experts and more than 500 software professionals working on services supporting laboratory instrumentation, bioinformatics and chemical informatics projects for leading companies.

Centre of excellence

To leverage the life sciences business, Persistent plans to set up a Life Sciences Centre of Excellence in Grenoble to expand into the European market. While bringing in new solutions and services to these, the centre will also provide it a platform to leverage its corporate technology position in areas such as cloud, analytics, mobility and collaboration.

Technology Roadshow

There is a technology roadshow organized by SkyQuest Technology Consulting (www.skyquestt.com) across some cities in India which will be a common platform for innovators and entrepreneurs of biotech/lifescience sector.  The whole idea, is to promote technology transfers and licensing of technologies through an IP marketplace.  At this event, around 50 technologies will be showcased in the form of presentations, prototypes, technology briefings and interactive sessions.  The buyers, representing nearly 50 Industry players across India are expected to discover novel potential technologies.


The roadshows will spearhead the best IP marketplace at four different destinations across India in the month of March 2011. 


15th - Vishakhapatnam | 17th - Hyderabad| 19th – Ahmedabad | 22nd - Vadodara 

Bio Saga - 2010 in review

The stats helper monkeys at WordPress.com mulled over how Bio Saga Blog did in 2010, and here’s a high level summary of its overall blog health:

The Blog-Health-o-Meter™ reads Fresher than ever.

Crunchy numbers

A helper monkey made this abstract painting, inspired by your stats.

A Boeing 747-400 passenger jet can hold 416 passengers. This blog was viewed about 3,000 times in 2010. That’s about 7 full 747s.

In 2010, there were 150 new posts, growing the total archive of this blog to 758 posts.

The busiest day of the year was June 8th with41 views. The most popular post that day was Computational Biologist @ Pfizer UK.

Where did they come from?

The top referring sites in 2010 were google.co.in, en.wordpress.com,emperan.com, obama-scandal-exposed.co.cc, anden.search.wordpress.com.

Some visitors came searching, mostly for list of pharma companies in noida, bioinformatics tools and softwares, ketan patel pfizer, h1n1 vaccine serum institute, and campus interviews 2010 in apticraft.

Attractions in 2010

These are the posts and pages that got the most views in 2010.

1

Computational Biologist @ Pfizer UK May 2010

2

5-Day Hands-on Workshop on Molecular Biotechnology and Bioinformatics September 2010
3 comments

3

Pune-based Serum Institute of India (SII) has developed a H1N1 vaccine May 2010

4

Abbott Laboratories Buys Piramal Healthcare Limited Biz for $3.72BMay 2010

5

Top 25 Indian Bioinformatics Companies July 2008
1 comment

New programming language will drive DNA

This is no Sci-Fi but reel to real! Yes we can in deed program the DNA for real Now! 

Bioinformatics scientists have built two logic gates for what they hope will become a new programming language for drug design as well as chemical and agricultural product engineering. The accomplishment seems hardly noteworthy except that these logic gates are made of E. coli. The two computational switches are based on two strains of the common bacterium. Researchers are now working to assemble them to perform computations.

This genetic programming software would resemble any other programming language, says Kevin Clancy, senior staff scientist for bioinformatics at Life Technologies Corp. The Carlsbad, CA, company is funding the work, which is being done by researchers at the UC San Francisco School of Pharmacy. Life Tech plans to commercialize the technology.

The software would convert instructions into a DNA sequence to be inserted into a bacterial, yeast or mammal cell. "It allows you to access and rewire biological systems on a scale that hasn't been possible in genetic engineering to date," says Christopher Voigt, UCSF associate professor.

Do you wish to know more?

Application/Resource Developer Position @ Linguamatics

Linguamatics is currently seeking a talented post graduate with experience of natural language processing to work on leading edge text mining products.

You will be responsible for developing and maintaining resources for domain specific adaptation of real-time semantic search software based on Natural Language Processing. Working closely with application scientists and the development team, you will ensure that the combination of software and resources satisfies customer requirements. This will include developing linguistic patterns, and programs to transform domain specific terminologies into common formats and keep them up-to-date. You will be working on life science applications, and some knowledge of the Pharmaceutical or Healthcare industry would be useful.In addition to resource and application development, you will be expected to contribute to ongoing UK or EU funded research projects as part of the research and resource development team.

You will have strong communication skills and be able to work with other staff to get across ideas and issues and to respond to requirements. You must also enjoy working in a fast-moving start-up environment, which requires multi-tasking, flexibility and the ability to work in a small, highly motivated team.

Requirements

The ideal candidate will have the following skills and experience:

• Post graduate qualification in computational linguistics or related discipline, including a good understanding of grammar.
• Research experience, preferably in a commercial setting
• Good interpersonal and communication skills
• Attention to detail
• Strong programming skills, ideally with experience of Java or C and a scripting language such as Perl

Additionally, the following attributes would be advantageous:

• Research experience, preferably in a commercial setting
• Background in or experience of the Life Science sector
• Experience in using ontologies

Company Profile

Linguamatics is a leading provider of text mining solutions based on innovative use of semantic and natural language processing (NLP) technology. Our software is acknowledged as the leading solution in the pharmaceutical and biotech industry and has been adopted by most of the top pharmaceutical companies.

This is a challenging and exciting role in a young, growing company. If you think you have the right skills and experience, and are ready to make an outstanding contribution to the team and the success of our business, please send your CV with a covering letter by email to:

Sarah Mansfield
Linguamatics Ltd
St Johns Innovation Centre
Cowley Rd
Cambridge CB4 0WS, UK

Email: jobs@linguamatics.com

www.linguamatics.com

Roche Restructuring Plan Includes 4,800 Job Cuts

Roche today announced a global restructuring plan, which includes reducing its global workforce by 4,800 jobs, most of which are in the firm's Pharmaceuticals Division.

The firm has dubbed the restructuring an "Operational Excellence Program" that is intended to result in annual cost savings of CHF2.4 billion ($2.4 billion). It expects to implement the changes, which also include the transfer of certain positions, consolidation at certain sites, and the closure of some facilities, during 2011 and 2012.

The 4,800 job cuts equates to 6 percent of Roche's global workforce. In addition to the reductions, it also expects to transfer around 800 jobs internally and approximately 700 positions to third parties.

The cost-cutting measure is not a surprise, as Roche had said in September that it would undertake such an initiative. However, the details of the effort were not announced until today.

Roche's Pharmaceuticals Division will bear the brunt of the cuts, with 5,400 jobs being affected. The firm said that it will reduce its pharma sales and marketing staff by a total of 2,650 positions. Another 1,350 jobs are expected to be affected by the reorganization of some technical operations within manufacturing at sites in California, Mannheim, Germany, and other places, which will cut around 750 positions, and includes Roche seeking buyers for its sites in Florence, SC, and Boulder, Col., which would affect 600 jobs.

Roche's cuts to R&D include discontinuing RNA interference research in Kulmbach, Germany, and in Nutley, NJ, and Madison, Wis.

Roche's Diagnostics Division, which includes its molecular tools and molecular diagnostics operations, will have 640 positions affected by the restructuring, though it appears the actions will affect the firm's blood gas diagnostics and diabetes care products. Its diagnostics chemical manufacturing and analytical services are expected to be discontinued in Mannheim and transferred to Penzberg, Germany.

"This is a comprehensive, focused initiative to reinforce Roche's long-term innovation capability in the face of increased price pressures and a more challenging market environment," Roche Group CEO Severin Schwan said in a statement.

Roche added that the restructuring effort "is a response to mounting cost pressures in healthcare — particularly in the US and Europe — and to increasing hurdles for the approval and pricing of new medicines."

The firm expects to incur one-time restructuring costs totaling CHF2.7 billion between 2010 and 2012, of which CHF1.5 billion are cash-related.

Roche re-affirmed its outlook for full-year 2010 of mid-single-digit sales growth in local currencies for the Roche Group and the Pharmaceuticals Division (excluding Tamiflu sales). It also said that sales for the Diagnostics Division are expected to grow significantly ahead of the market.

International Conference & Exhibition on Proteomics & Bioinformatics

OMICS Publishing Group invites you to attend the International Conference & Exhibition on Proteomics & Bioinformatics which is going to be held onJanuary 27-29, 2011 in Hyderabad, India. We welcome all the participants from across the globe to take part in this event.

International Conference & Exhibition on Proteomics & Bioinformatics will schedule and coordinate all meetings with our U.S and Indian organizers and representatives. International Conference & Exhibition on Proteomics & Bioinformatics will serve as a catalyst for the advancement of Proteomics & Bioinformatics by connecting scientists within and across disciplines at conferences and exhibitions held at venues that create an environment conducive to information exchange, generation of new ideas and acceleration of applications that benefit society.

The previous conference has played a leading role in facilitating interaction between researchers in Proteomics & Bioinformatics area. The 2011 meeting will continue this tradition of fostering cross-fertilization among different communities and contributing to an integrative approach to Proteomics & Bioinformaticsacross all scales of observation. The 2011 meeting will feature a scientific programme of comprehensive talks, special sessions and oral & poster presentations of peer-reviewed contributed papers.

To Collaborate the Scientific Professionals Around the world
Date of Conference	January 27-29, 2011
Venue Of Conference	Novotel & HICC Complex, Hyderabad
Spotlights	New Techniques for Proteome Analysis
Sponsors	Click Here Sponsorship Opportunities
Speaker Opportunity	Day 1: Available	Day 2: Available	Day 3: Available

Do you want to know more?